AIS Healthcare is the foremost leader in targeted drug delivery (TDD) and infusion care. It outperforms the role of a traditional pharmacy or nursing services provider and goes beyond these conventional labels, prioritizing meaningful actions. Their unwavering commitment lies in focusing on what truly matters, ensuring exceptional patient care and services. It delightfully shares its achievement on URAC accreditation for Specialty Pharmacy for its two advanced 503A pharmacies at Ridgeland and Dallas.

The founder of AIS, Chuck Bell, assumes the position of President of AIS. Having commenced his journey in the home infusion industry in 1992, Chuck has since played key roles in pharmacy and healthcare senior management. Additionally, he has established ownership of numerous home infusion pharmacies and other healthcare-related ventures. The CEO, Simon Castellanos, has served in this position since November 2016. With over 18 years of healthcare experience, before joining Healthcare, he served as the CEO of Western Dental, Inc.

AIS is dedicated to ensuring the safety of its clients and enhancing the quality of healthcare nationwide. They strive to improve the lives of every individual they serve by preparing and delivering prescriptions with utmost care. With a team of skilled nurses, AIS provides personalized care and support to patients, offering in-home Ig therapy to make their lives more convenient and comfortable.

AIS TDD operation is pivotal in preparing and delivering over 140,000 patient-specific prescriptions each year, with an average daily of approximately 550 prescriptions. The state requirements to produce medications of exceptional quality are surpassed here by the high standards set. Employing a proprietary process that combines aseptic processing with terminal sterilization, AIS Healthcare ensures unparalleled sterility assurance and extends the Beyond-Use Date (BUD) customized medication formulation.

Advanced Infusion Care (AIC) adopts a collaborative team approach to patient care, specifically for intravenous (IV) and subcutaneous (SubQ) immunoglobulin therapy. The AIC home infusion team, known for its national accreditation, assures the provision of patient-specific and specialized in-home infusion treatments by collaborating closely with doctors.

 The comprehensive evaluations conducted by state boards of pharmacy and regulatory agencies indicate excellent adherence to AIS Healthcare regulations. Also, AIS has gained acknowledgment from reputable independent pharmacy accreditors, namely URAC and the Accreditation Commission for Health Care (ACHC).